ARS Pharmaceuticals, Inc Net Asset Momentum
ARS Pharmaceuticals, Inc net asset momentum. ARS Pharmaceuticals, Inc (SPRY) recorded a net asset momentum of -55.5% as of December 2025, with net assets of $114.26 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore SPRY capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ARS Pharmaceuticals, Inc (2018–2025)
Net asset momentum of ARS Pharmaceuticals, Inc from 2018 to 2025. This chart tracks ARS Pharmaceuticals, Inc's year-over-year net asset growth across 8 annual reporting periods from 2018 to 2025. The most recent momentum reading is -55.5%, with net assets of $114.26 Million USD as of December 2025. See what is ARS Pharmaceuticals, Inc's book value for net asset value and shareholders' equity analysis.
ARS Pharmaceuticals, Inc Net Asset Momentum by Year (2018–2025)
ARS Pharmaceuticals, Inc net asset momentum by year from 2018 to 2025. The table below shows the complete annual net asset history for ARS Pharmaceuticals, Inc from 2018 to 2025, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see ARS Pharmaceuticals, Inc stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $114.26 Million | $327.65 Million | $213.39 Million | ▼ -55.5% |
| 2024 | $256.80 Million | $351.15 Million | $94.36 Million | ▲ +11.3% |
| 2023 | $230.76 Million | $233.19 Million | $2.43 Million | ▼ -15.4% |
| 2022 | $272.89 Million | $281.44 Million | $8.55 Million | ▲ +972.7% |
| 2021 | $-31.27 Million | $61.45 Million | $92.72 Million | ▼ -122.5% |
| 2020 | $-14.05 Million | $26.41 Million | $40.46 Million | ▼ -150.8% |
| 2019 | $-5.60 Million | $15.65 Million | $21.25 Million | ▼ -130.8% |
| 2018 | $18.20 Million | $27.55 Million | $9.35 Million | — |